You are here

Moony Tseng


Hong AL, Tseng YY, Cowley GS, et al. Integrated genetic and pharmacologic interrogation of rare cancers. Nat Commun. 2016 Jun 22;7:11987. 

Tseng YY, Bagchi A. The PVT1-MYC duet in cancer. Mol Cell Oncol. 2015;2(2): e974467.

Tseng YY, Moriarity BS, Gong W, et al. PVT1 dependence in cancer with MYC copy-number increase. Nature. 2014 Aug 7;512(7512):82-6.

Moony Tseng, Ph.D.

Yuen-Yi “Moony” Tseng is a senior research scientist II in the Cancer Program of the Broad Institute of MIT and Harvard, working under the direction of Bill Sellers. She is interested in developing technologies for modeling human cancer in order to improve treatment strategies and determine disease vulnerabilities and currently leads the R&D team of Cancer Cell Line Factory (CCLF) to create patient-derived ex vivo models at scale for cancers using systematic strategies and apply these new cancer models to the high-throughput drug sensitivity profiling pipeline.

Her accomplishments include earning a Platform Presenter Award from The LAM foundation in 2015, the 2013 Schmit-Steer Award from the Minnesota Medical Foundation, 2013 Keystone Symposia Scholarship (The Barrie Hesp Scholarship on behalf of Ashley Rebecca Cukier Scholarship), and the 2013 Agnes Hansen Award for Graduate Women in Science, among other honors.

Tseng holds a Ph.D. in molecular, cellular, developmental biology and genetics, cancer biology, from the University of Minnesota as well as an M.S. in bioengineering and biomedical engineering and a B.S. in environmental engineering technology from National Taiwan University.

Contact Moony Tseng via email at

March 2021